MARKET

ATYR

ATYR

Atyr Pharma Inc
NASDAQ
0.5296
+0.0466
+9.65%
Opening 15:57 05/20 EDT
OPEN
0.4976
PREV CLOSE
0.4830
HIGH
0.5460
LOW
0.4951
VOLUME
3.25M
TURNOVER
--
52 WEEK HIGH
7.29
52 WEEK LOW
0.3950
MARKET CAP
51.93M
P/E (TTM)
-0.7213
1D
5D
1M
3M
1Y
5Y
1D
aTyr Pharma Price Target Raised to $3.50/Share From $1.00 by Freedom Broker
Dow Jones · 7h ago
aTyr Pharma Raised to Buy From Hold by Freedom Broker
Dow Jones · 7h ago
aTyr Pharma upgraded to Buy from Hold at Freedom Broker
TipRanks · 10h ago
RBC Capital Sticks to Its Hold Rating for aTyr Pharma (ATYR)
TipRanks · 1d ago
Wells Fargo Sticks to Their Hold Rating for aTyr Pharma (ATYR)
TipRanks · 2d ago
Weekly Report: what happened at ATYR last week (0511-0515)?
Weekly Report · 2d ago
aTyr Pharma Inc options imply 30.5% move in share price post-earnings
TipRanks · 5d ago
Midday Fly By: Applied Materials, Figma post ‘beat and raise’ reports
TipRanks · 5d ago
More
About ATYR
aTyr Pharma, Inc. is a clinical-stage biotechnology company. The Company is leveraging evolutionary intelligence to translate tRNA synthetase biology into new therapies for fibrosis and inflammation. Its lead therapeutic candidate is efzofitimod, a first-in-class biologic immunomodulator in clinical development for the treatment of interstitial lung disease (ILD), a group of immune-mediated disorders that can cause inflammation and fibrosis, or scarring, of the lungs. Efzofitimod is a tRNA synthetase-derived therapy that selectively modulates activated myeloid cells through neuropilin-2 (NRP2) to resolve aberrant inflammation without immune suppression and potentially prevent the progression of fibrosis. ATYR0101 is a fusion protein derived from a domain of aspartyl-tRNA synthetase (DARS). ATYR0750 is a fusion protein derived from the domain of alanyl-tRNA synthetase (AARS). ATYR0750 is a novel ligand to fibroblast growth factor receptor 4 (FGFR4).

Webull offers aTyr Pharma Inc stock information, including NASDAQ: ATYR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ATYR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ATYR stock methods without spending real money on the virtual paper trading platform.